Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

<p><strong>Objectives</strong> The Heart Protection Study (HPS) provides an opportunity to assess directly the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial infarction, coronary death, stroke, or revascularization) in patients with peripher...

Descripció completa

Dades bibliogràfiques
Autor principal:	Heart Protection Study Collaborative Group
Altres autors:	The Society for Vascular Surgery
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2007
Matèries:	Blood Cardiovascular disease Vascular research Medical Sciences

Ítems similars

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
per: Heart Protection Study Collaborative Group
Publicat: (2002)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
per: Emberson, JR, et al.
Publicat: (2007)

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
per: Collins, R, et al.
Publicat: (2004)

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
per: Mihaylova, B, et al.
Publicat: (2005)

N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
per: Emberson, J, et al.
Publicat: (2005)

Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
per: Mihaylova, B, et al.
Publicat: (2005)

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].
per: Group, H
Publicat: (2005)

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial.
per: Bulbulia, R, et al.
Publicat: (2011)

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]
Publicat: (2005-03-01)

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
per: Mihaylova, B, et al.
Publicat: (2006)

The Association of Telangiectasias with Other Peripheral Vascular Lesions of Systemic Sclerosis
per: Bobeica C, et al.
Publicat: (2024-01-01)

Peripheral Vascular Injury
per: Patomphon Ekkarat, et al.
Publicat: (2014-12-01)

N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
per: Emberson, J, et al.
Publicat: (2005)

Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
per: Heart Protection Study Collaborative Group
Publicat: (2010)

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.
per: Armitage, J, et al.
Publicat: (2009)

Overview of Treatment Methods in Peripheral Major Vascular Injuries: A Retrospective Study
per: Rıfat Özmen, et al.
Publicat: (2020-11-01)

Peripheral vascular interventions : an illustrated manual /
per: Schroder, Jurgen, 1938-
Publicat: (c201)

Our Experience on Peripheral Vascular Trauma
per: Funda Tor, et al.
Publicat: (2012-08-01)

Tratamiento endovascular del trauma vascular periférico Endovascular treatment of peripheral vascular trauma
per: César Eduardo Jiménez, et al.
Publicat: (2012-12-01)

Peripheral vascular ultrasound : how, why, and when /
per: 346114 Thrush, Abigail, et al.
Publicat: (2005)

Peripheral vascular disease : basic diagnostic and therapeutic approaches /
per: Abela, George S.
Publicat: (2004)

Peripheral vascular remodeling during ischemia
per: Shigang Lin, et al.
Publicat: (2022-12-01)

Effect of cycle ergometry on peripheral blood flow, vascular conductance, and vascular resistance in young people
per: Dayane Guimarães, et al.
Publicat: (2022-06-01)

Mortalidad evitable por enfermedades vasculares periféricas Preventable mortality from peripheral vascular disease
per: Ulises de Jesús Gallardo Pérez, et al.
Publicat: (2008-12-01)

Unilateral vascular abnormality: A case of peripheral retinal arteriolar tortuosity associated with a prepapillary vascular loop
per: Parth S. Patel, et al.
Publicat: (2020-12-01)

Alternative access for peripheral vascular interventions
per: Andrea G. Alonso, MD, et al.
Publicat: (2023-09-01)

Vascular dysfunction in sporadic bvFTD: white matter hyperintensity and peripheral vascular biomarkers
per: Min Chu, et al.
Publicat: (2024-04-01)

Effect of hyperbaric oxygen therapy on peripheral vascular diseases
per: Spasojević Natalija, et al.
Publicat: (2017-01-01)

Peripheral Vascular Trauma among Vascular Surgery Cases Operated in a Tertiary Care Hospital: A Descriptive Cross-sectional Study
per: Sushil Dahal, et al.
Publicat: (2022-01-01)

Management of Suspected Peripheral Vascular Injuries in Orthopedic Trauma
per: Bo Li, et al.
Publicat: (2024-07-01)

Peripheral vascular catheter use in Latin America (the vascular study): A multinational cross-sectional study
per: Rachel M. Walker, et al.
Publicat: (2023-01-01)

Peripheral vascular complications following totally endoscopic cardiac surgery
per: Ling-chen Huang, et al.
Publicat: (2021-03-01)

Major Vascular Neurocognitive Disorder: A Reappraisal to Vascular Dementia
per: Emre Kumral, et al.
Publicat: (2017-03-01)

The effect of peripheral vascular interventions on future infrainguinal bypass
per: Doğan Kahraman, et al.
Publicat: (2019-03-01)

Use of peripheral vascular access in the prehospital setting: is there room for improvement?
per: Erin Gonvers, et al.
Publicat: (2020-06-01)

IL-19 and Other IL-20 Family Member Cytokines in Vascular Inflammatory Diseases
per: Michael V. Autieri
Publicat: (2018-04-01)

Polymorphous cutaneous sarcoidosis associated with peripheral vascular disease and its dermatoscopic findings
per: Balakrishnan Nirmal, et al.
Publicat: (2018-01-01)

FATAL VASCULAR COMPLICATION AT PERIPHERIC VA ECMO. IT IS POSSIBLE TO AVOID OR NOT?
per: E. S. Afonin, et al.
Publicat: (2019-02-01)

FATAL VASCULAR COMPLICATION AT PERIPHERIC VA ECMO. IT IS POSSIBLE TO AVOID OR NOT?
per: E. S. Afonin, et al.
Publicat: (2019-02-01)

Impact of Diabetes Mellitus on Peripheral Vascular Disease Concomitant with Coronary
per: Mehrab Marzban, et al.
Publicat: (2009-01-01)